Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Noriyoshi, Kanemura"'
Autor:
Yasushi, Ueki, Shoichi, Kuramitsu, Tatsuya, Saigusa, Keisuke, Senda, Hitoshi, Matsuo, Kazunori, Horie, Hiroaki, Takashima, Hidenobu, Terai, Yuetsu, Kikuta, Takayuki, Ishihara, Tomohiro, Sakamoto, Nobuhiro, Suematsu, Yasutsugu, Shiono, Taku, Asano, Kenichi, Tsujita, Katsuhiko, Masamura, Tatsuki, Doijiri, Yohei, Sasaki, Manabu, Ogita, Tairo, Kurita, Akiko, Matsuo, Ken, Harada, Kenji, Yaginuma, Noriyoshi, Kanemura, Shinjo, Sonoda, Hiroyoshi, Yokoi, Nobuhiro, Tanaka
Publikováno v:
Circulation Journal. 86:1329-1336
Little evidence is available regarding the long-term outcome in elderly patients after deferral of revascularization based on fractional flow reserve (FFR).Methods and Results: From the J-CONFIRM registry (long-term outcomes of Japanese patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3c6cb61680d4fdb774fdc6ccdf25619
https://doi.org/10.1253/circj.cj-21-1024
https://doi.org/10.1253/circj.cj-21-1024
Autor:
Satoko Hayakawa, Koji Ohashi, Rei Shibata, Ryotaro Takahashi, Naoya Otaka, Hayato Ogawa, Masanori Ito, Noriyoshi Kanemura, Mizuho Hiramatsu-Ito, Nobuo Ikeda, Toyoaki Murohara, Noriyuki Ouchi
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0153619 (2016)
OBJECTIVES:Follistatin-like 1 (Fstl1) is a circulating glycoprotein that plays a crucial role in cardiovascular diseases and inflammation-related disorders. We have shown that Fstl1 acts as an anti-inflammatory factor that protects against ischemic h
Externí odkaz:
https://doaj.org/article/7ab38a8fff7f4f50be6c8ac9fd3c4d9b
Autor:
Masanobu, Ishii, Shoichi, Kuramitsu, Kenshi, Yamanaga, Hitoshi, Matsuo, Kazunori, Horie, Hiroaki, Takashima, Hidenobu, Terai, Yuetsu, Kikuta, Takayuki, Ishihara, Tatsuya, Saigusa, Tomohiro, Sakamoto, Nobuhiro, Suematsu, Yasutsugu, Shiono, Taku, Asano, Katsuhiko, Masamura, Tatsuki, Doijiri, Fumitoshi, Toyota, Manabu, Ogita, Tairo, Kurita, Akiko, Matsuo, Ken, Harada, Kenji, Yaginuma, Noriyoshi, Kanemura, Shinjo, Sonoda, Hiroyoshi, Yokoi, Nobuhiro, Tanaka, Kenichi, Tsujita
Publikováno v:
European heart journal. Cardiovascular pharmacotherapy. 8(6)
Guideline-directed medical therapy (GDMT) is essential to prevent future cardiovascular events in chronic coronary syndrome (CCS) patients. However, whether achieving optimal GDMT could improve clinical outcomes in CCS patients with deferred lesions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::62723a789f8726290e83c8f3f041b13c
https://pubmed.ncbi.nlm.nih.gov/35512317
https://pubmed.ncbi.nlm.nih.gov/35512317
Autor:
Mari Kaneko, Takaya Abe, Rei Shibata, Satoko Hayakawa, Mikito Takefuji, Kazuhiro Matsuo, Toyoaki Murohara, Hayato Ogawa, Shukuro Yamaguchi, Takashi Enomoto, Masanori Ito, Mizuho Hiramatsu-Ito, Hiroshi Kawanishi, Takahiro Kambara, Daisuke Yuasa, Noriyoshi Kanemura, Naoya Otaka, Koji Ohashi, Noriyuki Ouchi
Publikováno v:
Cardiovascular Research. 116:237-249
AimsSecreted factors produced by adipose tissue are involved in the pathogenesis of cardiovascular disease. We previously identified adipolin, also known as C1q/TNF-related protein 12, as an insulin-sensitizing adipokine. However, the role of adipoli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e9653915b2cda1eb1171ed07bf53d23
https://doi.org/10.1093/cvr/cvz074
https://doi.org/10.1093/cvr/cvz074
Autor:
Noriyuki Ouchi, Rei Shibata, Koji Ohashi, Satoko Hayakawa, Daisuke Yuasa, Toyoaki Murohara, Naoya Otaka, Masanori Ito, Takashi Enomoto, Mizuho Hiramatsu-Ito, Noriyoshi Kanemura, Hayato Ogawa
Publikováno v:
Atherosclerosis. 257:138-145
Background and aims Obesity contributes to the progression of vascular disorders. C1q/TNF-related protein (CTRP) 1 is a circulating adipokine, which is upregulated in obese complications including coronary artery disease. Here, we investigated the ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5157000c9913c7211e38e83ca85f3487
https://doi.org/10.1016/j.atherosclerosis.2017.01.014
https://doi.org/10.1016/j.atherosclerosis.2017.01.014
Autor:
Noriyuki Ouchi, Takahiro Kambara, Hayato Ogawa, Naoya Otaka, Satoko Hayakawa, Koji Ohashi, Masanori Ito, Rei Shibata, Shinji Kihara, Toyoaki Murohara, Kazuhiro Matsuo, Takashi Enomoto, Mizuho Hiramatsu-Ito, Yusuke Uemura, Daisuke Yuasa, Noriyoshi Kanemura
Publikováno v:
Cardiovascular Research. 110:107-117
Aims Obesity is associated with the development of atherosclerosis. We previously demonstrated that omentin is a circulating adipokine that is downregulated in association with atherosclerotic diseases. Here, we examined the impact of omentin on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d79c38342a1fb0c4a50a481f2c85a3c
https://doi.org/10.1093/cvr/cvv282
https://doi.org/10.1093/cvr/cvv282
Autor:
Noriyuki Ouchi, Daisuke Yuasa, Naoki Mizutani, Noriyoshi Kanemura, Satoko Hayakawa, Yoshiyuki Kataoka, Takahiro Kambara, Toyoaki Murohara, Kazuhiro Matsuo, Hayato Ogawa, Rei Shibata, Mizuho Hiramatsu-Ito, Yusuke Uemura, Koji Ohashi, Takashi Murate, Masanori Ito
Publikováno v:
The FASEB Journal. 30:1065-1075
Obesity is associated with an increased risk of cardiovascular disease. C1q/TNF-related protein (CTRP)-1 is a poorly characterized adipokine that is up-regulated in association with ischemic heart disease. We investigated the role of CTRP1 in myocard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42a5c0cfd90cdbc4c424037d2b3c94b6
https://doi.org/10.1096/fj.15-279885
https://doi.org/10.1096/fj.15-279885
Autor:
Rei Shibata, Hiroyuki Daida, Noriyuki Ouchi, Toyoaki Murohara, Kazuhiro Matsuo, Daisuke Yuasa, Yusuke Joki, Mizuho Hiramatsu-Ito, Satoko Hayakawa, Takahiro Kambara, Koji Ohashi, Hayato Ogawa, Yoshiyuki Kataoka, Yusuke Uemura, Masanori Ito, Noriyoshi Kanemura
Publikováno v:
Circulation: Heart Failure. 8:342-351
Background— Myocardial infarction (MI) is one of the major causes of death worldwide. Chronic heart failure is a serious complication of MI that leads to poor prognosis. We recently found that neuron-derived neurotrophic factor (NDNF) is a proangio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e3ba446e56dfff8f423ea7dd042a5fd
https://doi.org/10.1161/circheartfailure.114.001647
https://doi.org/10.1161/circheartfailure.114.001647
Autor:
Toyoaki Murohara, Rei Shibata, Koji Ohashi, Nobuo Ikeda, Masanori Ito, Hayato Ogawa, Ryotaro Takahashi, Naoya Otaka, Noriyoshi Kanemura, Satoko Hayakawa, Noriyuki Ouchi, Mizuho Hiramatsu-Ito
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0153619 (2016)
PLoS ONE
PLoS ONE
Objectives Follistatin-like 1 (Fstl1) is a circulating glycoprotein that plays a crucial role in cardiovascular diseases and inflammation-related disorders. We have shown that Fstl1 acts as an anti-inflammatory factor that protects against ischemic h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::162b406dbf8b4a89b8e39fdbb49eb7a0
http://europepmc.org/articles/PMC4856269?pdf=render
http://europepmc.org/articles/PMC4856269?pdf=render
Autor:
Yusuke Joki, Yusuke Uemura, Toyoaki Murohara, Rei Shibata, Mizuho Hiramatsu-Ito, Daisuke Yuasa, Hayato Ogawa, Satoko Hayakawa, Hiroyuki Daida, Noriyuki Ouchi, Takahiro Kambara, Kazuhiro Matsuo, Koji Ohashi, Masanori Ito, Noriyoshi Kanemura
Publikováno v:
Biochemical and biophysical research communications. 459(1)
Ischemic heart disease is one of the leading causes of death. Fibroblast growth factor 21 (FGF21) is a circulating factor with an anti-diabetic property. Skeletal muscle is an important source of FGF21 production. Here, we investigated whether skelet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f98676e8f7ecf6477ee90b2d40e5a1a9
https://pubmed.ncbi.nlm.nih.gov/25712519
https://pubmed.ncbi.nlm.nih.gov/25712519